ethanolamine has been researched along with Obesity in 5 studies
Obesity: A status with BODY WEIGHT that is grossly above the recommended standards, usually due to accumulation of excess FATS in the body. The standards may vary with age, sex, genetic or cultural background. In the BODY MASS INDEX, a BMI greater than 30.0 kg/m2 is considered obese, and a BMI greater than 40.0 kg/m2 is considered morbidly obese (MORBID OBESITY).
| Excerpt | Relevance | Reference |
|---|---|---|
| " An endogenous fatty acid ethanolamine oleoyl ethanolamine (OEA) is reported to be capable of reducing body weight and food intake by increasing striatal extracellular dopamine concentration." | 3.96 | Development, validation and comparison of three LC-MS/MS methods for determination of endogenous striatal oleoyl ethanolamine in mice. ( Deng, Q; Guan, Y; Huang, J; Li, G; Long, L; Si, L; Soleimani Damaneh, M, 2020) |
| "Metabolic disorders such as type 2 diabetes, fatty liver disease, hyperlipidemia, and obesity commonly co-occur but clinical treatment options do not effectively target all disorders." | 2.44 | Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice. ( Alexopoulos, SJ; Beretta, M; Byrne, FL; Cantley, J; Chen, SY; Garcia, CJ; Hoehn, KL; Larance, M; Olzomer, EM; Philp, A; Salamoun, JM; Santos, WL; Shah, DP; Smith, GC; Turner, N, 2024) |
| "Gestational diabetes is a metabolic disorder affecting 2-5% of women and is a predictor of obesity, Type 2 diabetes mellitus and cardiovascular disease." | 1.32 | Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes. ( Crawford, MA; Ghebremeskel, K; Lowy, C; Min, Y; Thomas, B, 2004) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (20.00) | 29.6817 |
| 2010's | 1 (20.00) | 24.3611 |
| 2020's | 3 (60.00) | 2.80 |
| Authors | Studies |
|---|---|
| Fang, H | 1 |
| E-Lacerda, RR | 1 |
| Schertzer, JD | 1 |
| Chen, SY | 1 |
| Beretta, M | 1 |
| Olzomer, EM | 1 |
| Alexopoulos, SJ | 1 |
| Shah, DP | 1 |
| Byrne, FL | 1 |
| Salamoun, JM | 1 |
| Garcia, CJ | 1 |
| Smith, GC | 1 |
| Larance, M | 1 |
| Philp, A | 1 |
| Turner, N | 1 |
| Santos, WL | 1 |
| Cantley, J | 1 |
| Hoehn, KL | 1 |
| Guan, Y | 1 |
| Deng, Q | 1 |
| Li, G | 1 |
| Si, L | 1 |
| Long, L | 1 |
| Soleimani Damaneh, M | 1 |
| Huang, J | 1 |
| Sihag, J | 1 |
| Jones, PJH | 1 |
| Min, Y | 1 |
| Ghebremeskel, K | 1 |
| Lowy, C | 1 |
| Thomas, B | 1 |
| Crawford, MA | 1 |
5 other studies available for ethanolamine and Obesity
| Article | Year |
|---|---|
Obesity promotes a leaky gut, inflammation and pre-diabetes by lowering gut microbiota that metabolise ethanolamine.
Topics: Diabetes Mellitus, Type 2; Ethanolamine; Gastrointestinal Microbiome; Humans; Inflammation; Obesity; | 2023 |
Head-to-head comparison of BAM15, semaglutide, rosiglitazone, NEN, and calorie restriction on metabolic physiology in female db/db mice.
Topics: Animals; Caloric Restriction; Diabetes Mellitus, Type 2; Ethanolamine; Ethanolamines; Female; Mice; | 2024 |
Development, validation and comparison of three LC-MS/MS methods for determination of endogenous striatal oleoyl ethanolamine in mice.
Topics: Animals; Biosensing Techniques; Body Weight; Brain; Chromatography, High Pressure Liquid; Ethanolami | 2020 |
Dietary fatty acid composition impacts plasma fatty acid ethanolamide levels and body composition in golden Syrian hamsters.
Topics: Animals; Body Composition; Cricetinae; Dietary Fats; Energy Metabolism; Ethanolamine; Fatty Acids; H | 2018 |
Adverse effect of obesity on red cell membrane arachidonic and docosahexaenoic acids in gestational diabetes.
Topics: Adult; Arachidonic Acid; Choline; Diabetes Mellitus; Diabetes, Gestational; Docosahexaenoic Acids; E | 2004 |